These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7685417)
1. Screening for prostatic carcinoma with prostate specific antigen: results of the second year. Brawer MK; Beatie J; Wener MH; Vessella RL; Preston SD; Lange PH J Urol; 1993 Jul; 150(1):106-9. PubMed ID: 7685417 [TBL] [Abstract][Full Text] [Related]
2. Screening for prostatic carcinoma with prostate specific antigen. Brawer MK; Chetner MP; Beatie J; Buchner DM; Vessella RL; Lange PH J Urol; 1992 Mar; 147(3 Pt 2):841-5. PubMed ID: 1371559 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening in Tyrol, Austria: experience and results. Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519 [TBL] [Abstract][Full Text] [Related]
4. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR; Evans WP; Borden JD; Castellanos RD Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040 [TBL] [Abstract][Full Text] [Related]
5. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography]. Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer detection at low prostate specific antigen. Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982 [TBL] [Abstract][Full Text] [Related]
7. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC J Urol; 1994 May; 151(5):1283-90. PubMed ID: 7512659 [TBL] [Abstract][Full Text] [Related]
8. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy]. Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136 [TBL] [Abstract][Full Text] [Related]
9. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results. Reissigl A; Horninger W; Fink K; Klocker H; Bartsch G Cancer; 1997 Nov; 80(9):1818-29. PubMed ID: 9351555 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. Tsui KH; Chang PL; Wang TM; Hsieh ML Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. Ellis WJ; Chetner MP; Preston SD; Brawer MK J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men. Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755 [TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen]. Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. Fleshner NE; O'Sullivan M; Fair WR J Urol; 1997 Aug; 158(2):505-8; discussion 508-9. PubMed ID: 9224334 [TBL] [Abstract][Full Text] [Related]
16. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml. Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640 [TBL] [Abstract][Full Text] [Related]
17. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. Vallancien G; Prapotnich D; Veillon B; Brisset JM; Andre-Bougaran J J Urol; 1991 Nov; 146(5):1308-12. PubMed ID: 1719243 [TBL] [Abstract][Full Text] [Related]
18. The role of prostate-specific antigen as part of the diagnostic triad and as a guide when to perform a biopsy. Babaian RJ; Camps JL Cancer; 1991 Nov; 68(9):2060-3. PubMed ID: 1717134 [TBL] [Abstract][Full Text] [Related]
19. The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Smith DS; Humphrey PA; Catalona WJ Cancer; 1997 Nov; 80(9):1852-6. PubMed ID: 9351559 [TBL] [Abstract][Full Text] [Related]
20. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml. Kundu SD; Grubb RL; Roehl KA; Antenor JA; Han M; Catalona WJ J Urol; 2005 Apr; 173(4):1116-20. PubMed ID: 15758718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]